CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 276 filers reported holding CUBIST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $27,470,000 | +52.7% | 272,920 | +0.7% | 0.02% | +38.5% |
| Q3 2014 | $17,989,000 | -7.1% | 271,147 | -2.2% | 0.01% | 0.0% |
| Q2 2014 | $19,363,000 | -3.9% | 277,351 | +0.7% | 0.01% | -13.3% |
| Q1 2014 | $20,140,000 | +5.4% | 275,348 | -0.8% | 0.02% | 0.0% |
| Q4 2013 | $19,112,000 | +14.2% | 277,534 | +5.4% | 0.02% | +7.1% |
| Q3 2013 | $16,736,000 | +36.1% | 263,327 | +3.4% | 0.01% | +16.7% |
| Q2 2013 | $12,299,000 | – | 254,562 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quinn Opportunity Partners LLC | 328,000 | $33,013,000 | 15.74% |
| Cheyne Capital Management (UK) LLP | 373,372 | $37,593,000 | 9.88% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 897,136 | $90,296,000 | 9.71% |
| Andromeda Capital LLC | 76,760 | $7,726,000 | 9.71% |
| Palo Alto Investors LP | 1,303,668 | $131,214,000 | 7.70% |
| Andromeda Capital LLC | 50,000 | $5,033,000 | 6.32% |
| QVT Financial LP | 1,200,000 | $120,780,000 | 6.04% |
| HARVEST MANAGEMENT LLC | 42,500 | $4,278,000 | 6.03% |
| Sandell Investment Services LLC | 58,525 | $5,891,000 | 5.62% |
| Kellner Capital, LLC | 70,200 | $7,066,000 | 4.83% |